Innovative solutions to novel drug development in mental health
[摘要] There are many new advances in neuroscience and mental health which should lead to a greater understanding of the neurobiological dysfunction in neuropsychiatric disorders and new developments for early, effective treatments. To do this, a biomarker approach combining genetic, neuroimaging, cognitive and other biological measures is needed. The aim of this article is to highlight novel approaches for pharmacological and non-pharmacological treatment development. This article suggests approaches that can be taken in the future including novel mechanisms with preliminary clinical validation to provide a toolbox for mechanistic studies and also examples of translation and back-translation. The review also emphasizes the need for clinician-scientists to be trained in a novel way in order to equip them with the conceptual and experimental techniques required, and emphasizes the need for private-public partnership and pre-competitive knowledge exchange. This should lead the way for important new holistic treatment developments to improve cognition, functional outcome and well-being of people with neuropsychiatric disorders. (C) 2013 Elsevier Ltd. All rights reserved.
[发布日期] 2013-12-01 [发布机构]
[效力级别] [学科分类]
[关键词] Translation;Back-translation;Pharmacological tool box;Cognitive and psychosocial treatments;Novel drug development;Biomarkers;Neurobiological mechanisms;Neuropsychiatric disorders [时效性]